Koji Kimura

8PUBLICATIONS
0CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Characterisation of biological macromoleculesMolecular targetsClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 13, 2026
Practical considerations for empirical Bayes estimation using a pharmacokinetic/pharmacodynamic model developed from summary-level data of ustekinumab therapy in Crohn's disease.

|Dec 16, 2025
Pharmacokinetic and pharmacodynamic modelling of vedolizumab in Crohn's disease using summary level data and its application to model-informed precision dosing.

Koji Kimura, Atsushi Yoshida

|Jul 16, 2024
A prediction method for the individual serum concentration and therapeutic effect for optimizing adalimumab therapy in inflammatory bowel disease.

Koji Kimura, Atsushi Yoshida

|Jul 01, 2019
Prediction of clinical effects of infliximab administered for inflammatory bowel disease based on pharmacokinetic and pharmacodynamic modeling.

Koji Kimura, Atsushi Yoshida, Fumihiko Katagiri

|Nov 02, 2018
Comparisons of Usual Dose of Pharmaceutical Products Used in Japan and United States: Can Differences Be Explained by Pharmacokinetics Alone?

Risa Takayanagi, Yuuki Endo, Koji Kimura

|May 24, 2018
Pharmacokinetic and pharmacodynamic model for analysis of adalimumab administered for Crohn's disease.

Koji Kimura, Atsushi Yoshida, Risa Takayanagi

Pageof 2

Frequent Collaborators